artemether has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, L; Hong, S; Li, Y; Lin, X; Xiao, H; Yu, S; Zhu, X | 1 |
1 other study(ies) available for artemether and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
Topics: Animals; Artemether; Glucose; Lipid Metabolism; Lipids; Liver; Mice; Mice, Inbred C57BL; MicroRNAs; Non-alcoholic Fatty Liver Disease; PPAR alpha | 2023 |